|
|
|
| home > epc > spring 2003 > alternative statistical methods for conducting clinical trials - a personal regulatory insight |
|
|
 PUBLICATIONS |
European Pharmaceutical Contractor
|
Recent concerns about increasing research costs and long approval times have placed a renewed emphasis on the methodological aspects and design of clinical trials. However, it should be stated that these are not the only areas for concern. Many ethical considerations, from the constant demand to reduce the amount of recruited individuals, to the controversial views on the use of placebo groups, provide a wide forum for debate. 'Alternative' clinical trial models increasingly challenge the industry and the regulators but if regulatory awareness is increasing, the active role of the ethics committees is still in question.
There are three main groups of alternative approaches: specific designs; unusual statistical techniques; and the use of surrogate endpoints. When implementing alternative trial design a couple of important factors must be considered. Firstly the development of statistical techniques can be advantageous and create opportunities.
Secondly the 'classical' approach is often, if not always, inappropriate for trials involving medicinal products designated for the regulatory status of orphan drugs (1) or medication for rare diseases, thus posing problems for trials conducted in small populations and trials in paediatrics (2). Lastly, with particular reference to the assessment of efficacy, a higher number of new medicinal products' marketing authorisations are being granted predominantly (if not solely) on the basis of clinical surrogate endpoints. This situation also requires ongoing regulatory consideration.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
2012 BIO International Convention
18-21 June 2012, Boston, Massachusetts
Connect, partner and innovate at the 2012 BIO International Convention, June 18-21, Boston, Mass. Network with 15,000+ global biotech leaders in the BIO Business Forum, Exhibition and Programme.
More info >> |
|
 |
News and Press Releases |
 |
Topa Thermal Packaging introduces innovative pallet shipper
Topa Thermal Packaging has developed an innovative packaging for manufacturers that transport large quantities of temperature-sensitive products by road and air transport, such as vaccines and medicines. The ‘ClimateBox™ half PAG Pallet Shipper’ delivers significant time and cost savings, thanks to an efficient filling system.
More info >> |
|
|
